These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7039705)

  • 21. PGH2, TxA2 and PGI2 have potent and differentiated actions on human uterine contractility.
    Wilhelmsson L; Wikland M; Wiqvist N
    Prostaglandins; 1981 Feb; 21(2):277-86. PubMed ID: 7012935
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of Platelet thromboxane A2 and arterial prostacyclin by dietary vitamin E.
    Karpen CW; Merola AJ; Trewyn RW; Cornwell DG; Panganamala RV
    Prostaglandins; 1981 Oct; 22(4):651-61. PubMed ID: 6798639
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prostacyclin (PGI2) and thromboxane A2 interaction in vivo. Regulation by aspirin and relationship with anti-thrombotic therapy.
    Korbut R; Moncada S
    Thromb Res; 1978 Sep; 13(3):489-500. PubMed ID: 369028
    [No Abstract]   [Full Text] [Related]  

  • 24. Competitive antagonism at thromboxane receptors in human platelets.
    Armstrong RA; Jones RL; Peesapati V; Will SG; Wilson NH
    Br J Pharmacol; 1985 Mar; 84(3):595-607. PubMed ID: 2580580
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Arachidonic acid-induced platelet aggregation and thromboxane A2 generation in patients with coronary heart disease.
    Szczeklik A; Gryglewski RJ; Musiał J; Grodzínska L; Serwónska M; Wójcik-Switek L; Marcinkiewicz E
    Acta Biol Med Ger; 1978; 37(5-6):741-2. PubMed ID: 742286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of heparin on platelet aggregation and release and thromboxane A2 production.
    Mohammad SF; Anderson WH; Smith JB; Chuang HY; Mason RG
    Am J Pathol; 1981 Aug; 104(2):132-41. PubMed ID: 7258300
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pinane thromboxane A2: a TXA2 antagonist with antithrombotic properties.
    Aharony D; Smith JB; Smith EF; Lefer AM; Magolda RL; Nicolaou KD
    Adv Prostaglandin Thromboxane Res; 1980; 6():489-92. PubMed ID: 6992538
    [No Abstract]   [Full Text] [Related]  

  • 28. SIN-1, the main metabolite of molsidomine, inhibits prostaglandin endoperoxide analogue- and arachidonic acid-induced platelet aggregation as well as platelet thromboxane A2 formation.
    Block HU; Förster W; Heinroth I
    Arzneimittelforschung; 1982; 32(3):189-94. PubMed ID: 6896278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A possible role of thromboxane A2 (TXA2) and prostacyclin (PGI2) in circulation.
    Gryglewski RJ; Dembínska-Kieć A; Korbut R
    Acta Biol Med Ger; 1978; 37(5-6):715-23. PubMed ID: 369254
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of OKY-046, a selective thromboxane inhibitor, on prostaglandin production and function of pregnant rat uteri and platelets.
    Ghodgaonkar RB; Dubin NH
    Prostaglandins Leukot Med; 1987 Jan; 26(1):33-46. PubMed ID: 3468521
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Synthesis of thromboxane A2: limiting stages of primary thrombocyte aggregation in humans initiated by arachidonic acid and its metabolic products].
    Mevkh AT; Basevich VV; Varfolomeev SD
    Biokhimiia; 1984 Dec; 49(12):2035-40. PubMed ID: 6441604
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Binding of a radioiodinated 13-azapinane thromboxane antagonist to platelets: correlation with antiaggregatory activity in different species.
    Narumiya S; Okuma M; Ushikubi F
    Br J Pharmacol; 1986 Jun; 88(2):323-31. PubMed ID: 3730697
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prostaglandin endoperoxides, thromboxane A2 and adenosine diphosphate in collagen-induced aggregation of rabbit platelets.
    Lewis GP; Watts IS
    Br J Pharmacol; 1982 Apr; 75(4):623-31. PubMed ID: 6802211
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of selenium, vitamin E and vitamin C on human prostacyclin and thromboxane synthesis in vitro.
    Toivanen JL
    Prostaglandins Leukot Med; 1987 Mar; 26(3):265-80. PubMed ID: 3554268
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Membrane protein mediation of thromboxane A2-induced platelet aggregation.
    Kao KJ; Hagen PO; Pizzo SV
    Biochem Biophys Res Commun; 1980 Nov; 97(1):87-93. PubMed ID: 6779820
    [No Abstract]   [Full Text] [Related]  

  • 36. Constitutional thrombocytopathy with subnormal response to thromboxane A2.
    Samama M; Lecrubier C; Conard J; Hotchen M; Breton-Gorius J; Vargaftig B; Chignard M; Lagarde M; Dechavanne M
    Br J Haematol; 1981 Jun; 48(2):293-303. PubMed ID: 7195274
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thromboxane generation and platelet aggregation in survivals of myocardial infarction.
    Szczeklik A; Gryglewski RJ; Musiał J; Grodzińska L; Serwońska M; Marcinkiewicz E
    Thromb Haemost; 1978 Aug; 40(1):66-74. PubMed ID: 725852
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prostacyclins are only weak antagonists of coronary vasospasm induced by authentic thromboxane A2 and serotonin.
    Schrör K; Verheggen R
    J Cardiovasc Pharmacol; 1986; 8(3):607-13. PubMed ID: 2425180
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thromboxane production in the pregnant rat: differential recovery by platelets and uterus following aspirin administration.
    Dubin NH; Ghodgaonkar RB; Blake DA
    Biol Reprod; 1983 Oct; 29(3):743-9. PubMed ID: 6626652
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of insulin or tolbutamide treatment on 14C-arachidonic acid conversion to prostacyclin and/or thromboxane in lungs, aortas, and platelets of streptozotocin-induced diabetic rats.
    Valentovic MA; Lubawy WC
    Diabetes; 1983 Sep; 32(9):846-51. PubMed ID: 6354792
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.